The effects of doxapram on cerebral blood flow and peripheral hemodynamics in the anesthetized and unanesthetized goat.
The effects of doxapram on cerebral blood flow (CBF) and peripheral hemodynamics were evaluated in the goat after direct injection into the cerebral circulation and after peripheral IV administration. Doxapram injected centrally via the temporal artery, in doses too small to affect peripheral circulation, produced an immediate and prolonged decrease in CBF in both anesthetized and unanesthetized gohanges in blood CO2 concentration, since blood flow decreased immediately after injection and as reduction in CBF occurred in the absence of changes in blood CO2. Pheripheral IV administration of doxapram in clinical doses to anesthetized and unanesthetized goats produced a biphasic cardiovascular response. Cerebral blood flow, cardiac output, blood pressure, and heart rate decreased abruptly, but with the exception of CBF, these parameters returned to or exceeded preinjection values within 30 seconds. Cerebral blood flow slowly returned to preinjection values (within 10 minutes) and, in the case of unanesthetized animals and anesthetized animals ventilated with room air, rose substantially above preinjection levels, reaching a peak 20 minutes after injection. The latter observation is thought to be a compensatory reaction to the reduction in CBF; it was not evident in anesthetized animals ventilated with 100% O2.
D000758:Anesthesia; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004315:Doxapram / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006041:Goats; D006439:Hemodynamics / Q000187:drug effects*; D007267:Injections; D007275:Injections, Intravenous; D008954:Models, Biological; D010100:Oxygen
D002245:Carbon Dioxide; D004315:Doxapram; D010100:Oxygen